Skip to Content

APO LXR 500 (Levetiracetam extended release 500 mg)

Pill imprint APO LXR 500 has been identified as Levetiracetam extended release 500 mg.

Levetiracetam is used in the treatment of seizures; epilepsy; bipolar disorder; neuralgia; hyperekplexia (and more), and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 500 mg is not a controlled substance under the Controlled Substance Act (CSA).

Levetiracetam extended release 500 mg APO LXR 500
Levetiracetam extended release 500 mg APO LXR 500 Front
Levetiracetam extended release 500 mg APO LXR 500 Back
Levetiracetam extended release 500 mg APO LXR 500
Levetiracetam extended release 500 mg APO LXR 500
Levetiracetam extended release
Imprint:
APO LXR 500
Strength:
500 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Pyrrolidine anticonvulsants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Apotex Corp.
National Drug Code (NDC):
60505-3280
Inactive Ingredients:
hypromellose 2208 (15000 mPa.s)
silicon dioxide
hypromellose 2910 (5 mPa.s)
hydroxypropyl cellulose
polyethylene glycol 8000
titanium dioxide
water
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
60429-0349 Golden State Medical Supply (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide